Gross Profit - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Epizyme Inc
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
Gross Profit
$40.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Gross Profit
$36.7B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$21.5B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
4%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$8.9B
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$11.7B
CAGR 3-Years
3%
CAGR 5-Years
14%
CAGR 10-Years
18%

See Also

What is Epizyme Inc's Gross Profit?
Gross Profit
40.1m USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's Gross Profit amounts to 40.1m USD.

What is Epizyme Inc's Gross Profit growth rate?
Gross Profit CAGR 1Y
68%

Over the last year, the Gross Profit growth was 68%.

Back to Top